Opthea : Angiogenesis 2022 -Prof Cheung presentation of PCV data

OPT-302 Combination Therapy in onlyPolypoidal Choroidal Vasculopathy


useGemmy Cheung MBBS, FRCOphth, FAMS, MCI


Head and Senior Consultant,
... | February 13, 2022

Related Keywords

,Opthea Group ,Exchange Commission ,Opthea Or Company ,Opthea Limited ,Opthea Limited Stock Exchange ,News ,Information ,Press Release ,Combination ,Therapy ,N ,Nlypolypoidal ,Horoidal ,Segemmy ,Cheung ,Head ,End ,Enior Opt Au000000opt2 ,